. .

 
Zuruecksetzen

Suchergebnis - ROCHE HOLDING AG INHABER-AKTIEN SF 1

Zeit Titel
28.06 13:36dpa-AFX: Roche-Medikamente Piasky und Vabysmo erhalten positive Empfehlungen
28.06 13:31dpa-AFX: *ROCHE: VABYSMO ERHÄLT CHMP-EMPFEHLUNG FÜR DIE DRITTE INDIKATION
28.06 13:15Press Release: Roche's Vabysmo gets CHMP -3-
28.06 13:15Press Release: Roche's Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO)
28.06 13:15Press Release: Roche's Vabysmo gets CHMP -2-
28.06 13:15dpa-AFX: GNW-Adhoc: Roche's Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO)
28.06 13:00Press Release: CHMP recommends EU approval of Roche's PiaSky for people with PNH, a rare, life-threatening blood condition
28.06 13:00Press Release: CHMP recommends EU approval of -2-
28.06 13:00dpa-AFX: GNW-Adhoc: CHMP recommends EU approval of Roche's PiaSky for people with PNH, a rare, life-threatening blood condition
27.06 17:51Aktien Schweiz mit leichten Abgaben
27.06 07:00dpa-AFX: GNW-Adhoc: Roche expands access to cervical cancer screening tools with two new WHO prequalification designations, including HPV self-collection
27.06 07:00Press Release: Roche expands access to cervical cancer screening tools with two new WHO prequalification designations, including HPV self-collection
27.06 07:00Press Release: Roche expands access to cervical -2-
26.06 17:48Aktien Schweiz erneut mit Abschlägen
25.06 17:48Aktien Schweiz nach deutlichem Vortagesplus mit Abgaben
25.06 07:24Roche erhält EU-Zulassung für Multiple-Sklerose-Mittel
25.06 07:00Press Release: Roche's OCREVUS subcutaneous administration approved by European Commission, as first and only twice-a-year injection for relapsing and primary progressive multiple sclerosis
25.06 07:00Press Release: Roche's OCREVUS subcutaneous -2-
25.06 07:00dpa-AFX: GNW-Adhoc: Roche's OCREVUS subcutaneous administration approved by European Commission, as first and only twice-a-year injection for relapsing and primary progressive multiple sclerosis
24.06 17:42Aktien Schweiz fest - Pharmawerte gesucht

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH